Suppression of Bcl-2 Messenger RNA Production May Mediate Apoptosis after Ionizing Radiation, Tumor Necrosis Factor α, and Ceramide

Cancer Research

Volumn 55, Issue 5, 1995, Pages 991-994

  Chen, Mei ^a   Quintans, Jose ^a   Fuks, Zvi ^b   Thompson, Craig ^a   Kufe, Donald W ^c   Weichselbaum, R R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; DNA FRAGMENT; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMAN; HUMAN CELL; IONIZING RADIATION; LEUKEMIA CELL LINE; MESSENGER RNA SYNTHESIS; PRIORITY JOURNAL; RADIATION DOSE;

APOPTOSIS; BASE SEQUENCE; CELL DEATH; CERAMIDES; COMBINED MODALITY THERAPY; DNA DAMAGE; DNA, NEOPLASM; DOWN-REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION, LEUKEMIC; HUMAN; LEUKEMIA; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR;

EID: 0028928295     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Yamada, T., and Chyama, H. Radiation-induced interphase death of rat thymocytes is internally programmed (apoptosis). Int. J. Radiat. Biol., 53: 64–78, 1988.
2. Allan, D. J. Radiation-induced apoptosis: its role in a MADCAT (mitosis-apoptosis-differentiation-calcium toxicity) scheme of cytotoxicity mechanisms. Int. J. Radiat. Biol., 62: 145–152, 1992.
3. Urmansky, S. R. Apoptotic process in radiation induced death of lymphocytes. In: L. N. Tonei and E. O. Cope (eds.), Apoptosis: The Molecular Basis of Cell Death, pp. 193–208. New York: Cold Spring Harbor Laboratory, 1991.
4. Potten, C. S. Extreme sensitivity of some intestinal crypt cells to a and 7 irradiation. Nature (Lond.), 269: 518–521, 1977.
5. Meyn, R. E., Stephens, L. C., Ang, K. K., Hunter, N. R., Brock, W. A., Milas, L., and Peters, L. J. Heterogeneity in the development of apoptosis in irradiated murine tumors of different histologies. Int. J. Radiat. Oncol. Biol., 64: 583–591, 1993.
6. Stephens, L. C., Hunter, N. R., Ang, K. K., Milas, L., and Meyn, R. E. Development of apoptosis in irradiated murine tumors as a function of time and dose. Radiat. Res., 135: 75–80, 1993.
7. Meyn, R. E., Stephens, L. C., Voehringer, D. W., Story, M. D., Mirkovic, N., and Milas, L. Biochemical modulation of radiation-induced apoptosis in murine lymphoma cells. Radiat. Res., 136: 327–334, 1993.
8. Elias, E., Moore, P. B., and Rose, S. M. Tumor necrosis factor induced DNA fragmentation of HL-60 cells. Biochem. Biophys. Res. Commun., 157: 963–969, 1988.
9. Greenblatt, M. S., and Elias, L. The type B receptor for tumor necrosis factor-cα mediates DNA fragmentation in HL-60 and U937 cells and differentiation in HL-60 cells. Blood, 80: 1339–1346, 1992.
10. Fesel, K., Kolb-Bachofen, V., and Kolb, H. Analysis of TNF-α induced strand breaks at the single cell level. Am. J. Pathol., 139: 251–254, 1991.
11. Fulton, A. M., and Chong, Y. C. The role of macrophage-derived TNF-a in the induction of sublethal tumor cell DNA damage. Carcinogenesis (Lond.), 13: 77–81, 1992.
12. Kim, M-Y., Linardic, C., Obeid, L., and Hannun, Y. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor and γ-interferon. J. Biol. Chem., 266: 484–489, 1991.
13. Dressier, K. A., Mathias, S., and Kolesnick, R. N. Tumor necrosis factor-cr activates the sphingomyelin signal transduction pathway in a cell-free system. Science (Washington DC), 255: 1718, 1992.
14. Jarvis, W. D., Kolesnick, R. N., Fornari, F. A., Taylor, R. S., Gewirtz, D. A., and Grant, S. Induction of apoptotic cell death by sphingomyelinase and ceramide in a variety of mammalian cells. Proc. Natl. Acad. Sci. USA, 91: 73–77, 1990.
15. Kolesnick, R., and Golde, D. W. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signalling. Cell, 77: 325–328, 1994.
16. Haimovitz-Friedman, A., Kan, C. C., Ehleiter, D., Persaud, R. S., McLoughlin, M., Fuks, Z., and Kolesnick, R. N. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J. Exp. Med., 180: 525–535, 1994.
17. Hallahan, D. E., Beckett, M. A., Kufe, D., and Weichselbaum, R. R. The interaction between recombinant human tumor necrosis fact and radiation in 13 human tumor cell lines. Int. J. Radiat. Oncol. Biol. Phy., 19: 69–74, 1990.
18. Weichselbaum, R. R., Hallahan, D. E., Beckett, M. A., Mauceri, H. J., Lee, H., Sukhatme, V. P., and Kufe, D. W. Gene therapy targeted by radiation preferentially radiosensitizes tumor cells. Cancer Res., 54: 4266–4269, 1994.
19. Hallahan, D. E., Spriggs, D. R., Beckett, M. A., Kufe, D. W., and Weichselbaum, R. R. Increased tumor necrosis factor α mRNA after cellular exposure to ionizing radiation. Proc. Natl. Acad. Sci. USA, 86: 10104–10107, 1989.
20. Geary, M., Smith, S., and Sklar, J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell, 47: 19–28, 1986.
21. Tsujimoto, Y., Gorham, J., Cossmen, J., Jaffe, E., and Croce, C. M. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science (Washington DC), 229: 1390–1393, 1985.
22. Tsujimoto, Y., Finger, L. R., Yunis, J., Nowell, P. C., and Croce, C. M. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14:18) chromosome translocation. Science (Washington DC), 226: 1097–1099, 1984.
23. Tsujimoto, Y., and Croce, C. M. Analysis of the structure, transcripts, and protein products of Bcl-2, the gene involved in human follicular lymphomas. Proc. Natl. Acad. Sci. USA, 83: 5214–5218, 1988.
24. Sentman, C. L., Shutter, J. R., Hockenbery, D., Kanagaa, O., and Korsmeyer, S. J. Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell, 67: 879–888, 1991.
25. Stasser, A., Harris, A. W., and Cory, S. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell, 67: 889–899, 1991.
26. Hockenbery, D., Nunez, G., Milliman, C., Schieiber, R. D., and Korsmeyer, S. J. Bcl-2 is an inner mitochondria membrane protein that blocks programmed cell death. Nature (Lond.), 348: 334–346, 1990.
27. Hockenbery, D. M., Oltvai, Z. N., Yin, S-M., Milliman, C. L., and Korsmeyer, S. J. Bcl-2 function in an antioxidant pathway to prevent apoptosis. Cell, 75: 241–251, 1993.
28. Oltvai, Z. N., Milliman, C. L., and Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homology Box that accelerates programmed cell death. Cell, 74: 609–619, 1993.
29. Yin, X. M., Oltvai, Z. N., and Korsmeyer, S. J. BH1 and BH2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature (Lond.), 369: 321–323, 1994.
30. Boise, L. H., Gonzalez, G. M., Postema, C. E., Ding, L. Y., Lindsten, T., Turka, L. A., Mao, X. H., Nunez, G., and Thompson, C. B. Bcl-x, a 6c/-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74: 597–608, 1993.
31. Traganos, F., Kauscinski, J., Gong, J. P., Ardelt, B., Darzykiewicz, R. J., and Darzynkiewicz, Z. Caffeine prevent apoptosis and cell cycle effects induced by camptothecin or to potecan in HL-60 cells. Cancer Res., 53: 4613–4618, 1993.
32. Wang, S. Y., and Gudas, L. J. Isolation of cDNA clones specific for collagen IV and laminin from mouse teratocarcinoma cells. Proc. Natl. Acad. Sci. USA, 80: 5880–5884, 1983.
33. Wyllie, A. H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (Lond.), 284: 555–556, 1980.
34. Manome, Y., Datta, R., Taneja, N., Shafrnan, T., Bump, E., Hass, R., Weichselbaum, R., and Kufe, D. Coinduction of c-jun gene expression and interaucleosomal DNA fragmentation by ionizing radiation. Biochemistry, 32: 10607–10613, 1993.
35. Weichselbaum, R. R. Cellular and molecular aspects of human tumor radioresistancc. In: V. T. De Vita, S. Hellman, and S. A. Rosenberg (eds.), Important Advances in Oncology, pp. 73–83. Philadelphia: J. B. Lippincott Co., 1991.